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Background: Food insecurity in sub-Saharan Africa and malnutrition constitute the main obstacles for successful
treatment of people living with HIV/AIDS (PLWH). The aim of this study was to assess the effect of consuming daily
100 g RUTF (ready-to-use therapeutic food) as supplement, on body composition, anemia and zinc status of
hospitalized PLWH in Senegal.
Methods: A Controlled clinical trial was conducted in 65 PLWH randomly allocated to receive either standard hospital
diet alone (Control group: n = 33), or the standard diet supplemented with 100 g RUTF/day (RUTF group: n = 32).
Supplementation was continued at home during 9 weeks. Individual dietary intakes were measured and compared to
the Recommended Dietary Allowances. Body composition was determined using Bio-Impedance Analysis. Hemoglobin
was measured by HemoCue and plasma zinc (PZ) concentration by atomic absorption spectrometry. PZ was adjusted
to infection (CRP and α1-AGP). All measures were conducted on admission, discharge and after 9 weeks home-based
follow up.
Results: 34 and 24 % of the patients in RUTF and Control groups were suffering from severe malnutrition
(BMI < 16 kg/m2), respectively. In both groups, more than 90 % were anemic and zinc deficiency affected over 50 % of
the patients. Food consumed by the Control group represented 75, 14 and 55 % of their daily recommended
intake (DRI) of energy, iron and zinc, respectively. When 100 g of RUTF was consumed with the standard diet,
the DRI of energy and zinc were 100 % covered (2147 kcal, 10.4 mg, respectively), but not iron (2.9 mg).
After 9 weeks of supplementation, body weight, and fat-free mass increased significantly by +11 % (p = 0.033),
and +11.8 % (p = 0.033) in the RUTF group, but not in the Control group, while percentage body fat was
comparable between groups (p = 0.888). In the RUTF group, fat free mass gain is higher in the patients on ART
(+11.7 %, n = 14; p = 0.0001) than in those without ART (+6.2 %, n = 6; p = 0.032). Anemia decreased significantly
with the supplementation, but zinc status, measured using plasma zinc concentration, remained unchanged.
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Conclusion: Improving PLWH’ diet with 100 g RUTF for a long period has a positive impact on muscle mass and
anemia but not on the zinc status of the patients.
Trial number: NCT02433743, registered 29 April 2015.
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Malnutrition is one of the major complications among
PLWH (people living with HIV/AIDS) infection and a
significant factor in advancing the disease. Wasting syn-
drome, closely associated with mortality and morbidity,
is defined as a weight loss of at least 10 % in the pres-
ence of diarrhea or chronic weakness and documented
fever for at least 30 days [1]. HIV-associated wasting was
recognized as a negative prognostic indicator and as re-
ported by Tabi & Vogel in Ghana, more patients with
HIV/AIDS die because of their poor nutritional status
rather than the disease itself [2]. Furthermore, malnour-
ished PLWH have a higher risk of death and suboptimal
response to treatment especially when antiretroviral
therapy (ART) is initiated [3]. Indeed, studies of body
composition have demonstrated that during the wasting
syndrome, depleted level of body cell mass, which con-
tains the metabolically active tissue rather than weight
loss [4], have been associated with increased risk of
death [5, 6]. Wasting in most cases results from a com-
bination of factors, including drug use, medications,
concurrent diseases, and HIV itself. However, reduced
energy intake is suggested as the primary determinant of
HIV-related wasting syndrome [7, 8]. Therefore, there
has been considerable interest in the measurement of
body composition in patients with HIV/AIDS infection.
Such measurements can be useful in conjunction with
well-maintained weight records to characterize an indi-
vidual’s response to various medical or nutritional inter-
ventions. Many approaches have been used to reverse
weight loss in HIV-infected people, including appetite
stimulants, anabolic agents, cytokine inhibitors and hor-
mones [9–11]. In resource-limited settings where malnu-
trition is the second complication of HIV infection,
nutritional intervention programs should be a priority
for the successful care of PLWH [12, 13]. In Senegal, we
have demonstrated that daily supplementation with 43 g
RUTF, a ready to use peanut-based therapeutic food,
when mixed with millet porridge provided an additional
energy intake of 245 kcal/d, and had a positive impact
on body composition, particularly by increasing fat free
mass and active cell mass among adults HIV-outpatient
with chronic malnutrition [14]. Ndekha et al. in Malawi
showed a significant improvement on body mass index
(BMI) and fat free mass in adult PLWH supplementedwith 245 g RUTF/d providing 1362 kcal, 35.5 g protein,
78 μg of selenium, and 8 mg of zinc [15]. Recently,
in South Africa, Evans et al. [16] in a randomized
study showed a positive effect of supplementation
with a high-protein high-energy meal (100 g equiva-
lent to 388 kcal/d). Others authors have found similar
results on body composition using different supple-
ments [14, 17, 18]. In most of these studies, no sig-
nificant difference was reported on CD4, viral load
and quality life. However, the most important obser-
vation was that none of these diets did not provide
enough zinc to cover the normal zinc requirement of
the patients [12, 14, 15, 17], although data from the
literature showed that zinc deficiency remains a major
problem in PLWH. During HIV infection, zinc defi-
ciency is associated with loss of appetite, disease
progression and increased morbidity and mortality
[19, 20]. Mocchegiani et al. showed that supplementa-
tion with zinc at doses approximately 3 times the
RDA significantly increased weight, plasma zinc con-
centration, CD4 count and reduced the incidence of
opportunistic infections in PLWH [21]. World Health
Organization (WHO) recommended that at least 1
RDA of zinc should be daily provided to PLWH [22].
In Senegal, the supplementation of PLWH with 43 g
RUTF/d covered 86 % of the daily recommended in-
take of zinc [14]. It is likely that the dose provided
daily in this previous study was inadequate (<1 RDA)
to cover the zinc requirement of the patients. It is
also possible that a low efficiency of zinc absorption
from the supplement had occurred due to the pres-
ence of phytates in the RUTF and the millet porridge.
Millet and RUTF contain a noticeable amount of phy-
tates, and it is now well known that zinc bioavailabil-
ity is affected by the amounts of phytates consumed
with the meal [23, 24]. In view of these above consid-
erations, we decided to increase the daily consump-
tion of RUTF (100 g /d) in order to meet at least
one RDA of zinc requirement while maintaining the
additional amount of energy consumed as recommended
by WHO for PLWH. We also replaced the millet porridge
with rice porridge that contains less myo-inositol
phosphate. Hence, the present study was designed to
measure the effect of 100 g/d RUTF consumed with
rice porridge on body composition, anemia and zinc
Table 1 Nutrient composition of the supplement and
percentage coverage of daily recommended intake
Total Per %
Intakesa 100 kcal Coverageb
Macronutrients
Energy kcal 567.7 - 25.3
Protein (g) 14.2 2.5 27.9
Carbohydrate (g) 49.3 8.7 37.9
Lipids (g) 35.8 6.3 130.1
Vitamins
Vitamin A (μg) 910 160.3 132
Vitamin D (μg) 16 2.8 320
Vitamin E (mg) 20.0 3.5 133.4
Vitamin C (mg) 53 9.3 177.7
Vitamin B1 (mg) 0.6 0.1 53.0
Vitamin B2 (mg) 1.8 0.3 150
Vitamin B6 (mg) 0.6 0.1 47.7
Vitamin B12 (μg) 1.8 0.3 75
Vitamin K (μg) 21 3.7 35
Biotin (μg) 65 11.4 216.7
Folic Acid (μg) 211.8 37.3 53.0
Pantothenic acid (mg) 3.1 0.5 62
Niacin (mg) 5.3 0.9 35.3
Minerals
Calcium (mg) 320.9 56.5 32.1
Phosphorus (mg) 403.3 71.0 57.6
Potassium (mg) 1119.9 197.3 23.8
Magnesium (mg) 95.2 16.8 39.7
Zinc (mg) 7c 1.2 194
Copper (mg) 1.8 0.3 89
Iron (mg) 0.6d 0.1 6.2
Iodine (μg) 110 19.4 73.3
Sodium (mg) 189.4 33.4 12.6
Selenium (μg) 30 5.3 100
aSupplement =100 g RUTF + 100 g rice porridge
b% nutrient coverage calculated using FAO/OMS (2002, 2004)
cZinc intake calculated based on the bioavailability of zinc in mixed diets
(Hotz and Brown, 2004)
d% iron intake based on the bioavailability of iron (5 %) in the supplement
(FAO/OMS, 1989)
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period. We hypothesized that such supplement would sig-
nificantly improve the nutritional status of PLWH.
Methods
Study setting and subjects
The study was conducted from October 2011 to Jun
2012 at the Service des maladies infectieuses (SMI),
located in the Centre Hospitalier National Universitaire
de Fann (CHNU), Dakar, Senegal (West Africa). Upon
admission and clinical examination, the eligibility of the
patients enrolled in the study was established as follows:
HIV/AIDS men and women at any WHO stages of the
disease, under antiretroviral (ART) treatment or not,
without psychiatric illness, not diabetic, without long
term physical disability, and inability to eat. The study
was approved by the Ethical Committee of the Ministry
of Health of Senegal and registered with the National
Institutes of Health as a clinical trial number
NCT02433743. Prior to participation, the patients were
informed about the study objectives and procedures, and
their written consent was obtained.
Study design
The study was designed as a randomized, controlled trial
with one treatment group and a Control group. Eligible
sixty-five (65) HIV- infected adults hospitalized in the
SMI were randomly allocated to receive either standard
hospital diet (Control group: n = 33), or standard hospital
diet supplemented with RUTF (RUTF group: n = 32).
Sample-size calculations was based on the expected differ-
ence of 2.3 ± 2.1 kg in change in fat free mass between
group from baseline to 9 week, with a 90 % power and
5 % significance level. The enrollment of the patients was
carried out by the clinician. The randomization and as-
signment to group was performed by the senior researcher
using a computer-generated random number list (EPI
INFO 6.0; Centers for Disease Control and Prevention,
Atlanta).
Diet and nutritional supplement
During hospitalization, the Control group received a
standard hospital diet that consisted of three local
meals/d (breakfast, lunch and dinner). The meals were
provided either by the hospital or by the patient’s relatives.
The RUTF group received daily, in addition to the stand-
ard hospital diet, 200 g of supplement (100 g RUTF mixed
with 100 g of rice porridge). The rice porridge (9.1 g rice
flour per 100 ml water) was prepared extemporaneously,
mixed with the RUTF, and served immediately. RUTF is
composed of peanut butter and skimmed milk powder
fortified with a vitamin-mineral complex commercialized
by Nutriset. Our laboratory tested RUTF for the first time
during the rehabilitation of children suffering from severeand acute malnutrition [13]. All meals were served at
7:00 AM, 1:00 PM and 6:00 PM. The supplement was
served twice (2 × 100 g) daily: at 11:00 AM and
5:00 PM. In addition, all the patients (Control and
RUTF) received a vegetable-based soup from the
micro-garden of the hospital at 12:00 AM.
The nutrient composition of the supplement and per-
centage coverage of nutrient requirements relative to
RDA are shown in Table 1. At discharge, each patient of
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for home-based supplement preparation. Both groups
received dietary counseling to improve their diet at
home. Clinical follow-up was performed in both RUTF
and Control groups over a 3 months period (during
hospitalization, and 9 weeks after). Anthropometry, body
composition (fat free mass, fat mass, % body fat), anemia,
zinc and infectious status were measured on admission, at
discharge, and after 9 weeks follow-up.
Dietary assessment
Dietary intakes were measured during 7 consecutive days
in 10 randomly selected subjects from each group during
the hospitalization period. Individual ration of each meal
served by the hospital or provided by the relatives was
weighed with a food scale (i-Balance 2600 Myweigh, Scale
Company, Phoenix, USA). At the end of the meal, the re-
mains (R) were weighed. Thus, the difference between the
amount served and the remaining amount was used to
calculate the exact amount of food consumed by the pa-
tient. Nutrient intakes were calculated using the African
food composition tables [25] and Nutrisurvey/ENA soft-
ware, and were compared to RDA [26, 27].
Anthropometry
Anthropometric measurements were performed using
standard procedures. Measure of height was made using
height board (SECA 216, GmbH et Co, Hamburg,
Germany), to the nearest millimeter. Body weight was
measured with an electronic scale (SECA 877, GmbH &
Co, Hamburg, Germany), with a maximal range of 200 kg
and a precision of 100 g. The measures were made in
duplicate without clothing.
Body composition
Body composition was measured using Bioelectrical
Impedance Analysis (BIA) with a multifrequency ana-
lyser (Xitron 4000B, Xitron Technologies, California,
USA). The accuracy of the instrument was tested before
the measurements by using a 422Ω standard resistor
purchased with the analyzer. The resistance and react-
ance values of measurements are given to the nearest 0.1
Ω from a digital display. Total body water (TBW) was
predicted from the equation developed by Diouf et al.
in HIV-infected people in Senegal: TBW (kg) =
0.3756(height2/R1000) + 0.1717(weight) – 0.5756 [28]. Fat
free mass, fat mass and % body fat were calculated.
Blood sampling and analysis
Blood sampling was performed in the morning between
8:00–10:00 AM on admission, at discharge and after
9 week home follow-up. All blood collection and process-
ing procedures were conformed to the recommendationsof the International Zinc Nutrition Collaborative Group:
IZiNCG [29]. Blood was collected into trace element–free
polyethylene zinc-free tubes containing lithium heparin
anticoagulant, and centrifuged shortly after. The time of
the sample collection and of the most recent food intake
were noted and used to adjust for this interval in the data
analysis. The reason for this statistical adjustment for the
time interval between the last meal and the blood collec-
tion was to minimize the variability due to known meal-
related effects on plasma zinc concentrations. Hemoglobin
concentration was measured by using a HemoCue pho-
tometer (HemoCue Hb 201+; HemoCue AB, Angelholm,
Sweden). Immunocytometry (Becton Dickinson FACS
count Immunocytometry systems, California) determined
the CD4 cell count in total blood using FACS count kits
reagent (Becton Dickinson, BD Bioscience). Blood samples
were centrifuged at 3200 rpm (EBA 20 centrifuge model
2002; Andreas Hettich GmbH & Co KG, Tuttlingen,
Germany) during 12 min and plasma samples were col-
lected in trace element-free cryovials and stored at−80 °C
in the laboratory until assays. All the analysis was per-
formed in the Laboratory of Nutrition, University Cheikh
Anta Diop of Dakar. Plasma zinc (PZ) concentrations were
measured in duplicate by atomic absorption spectropho-
tometry (AA800 Model, Perkin-Elmer Corporation,
Norwalk, USA). Quality control of the measurements was
performed using the reference material randox assay
human serum level 2 (Randox, Antrim, UK). Internal
pooled plasma control was run with each batch of sample.
Plasma α-1 acid glycoprotein (AGP) and C-reactive protein
(CRP) concentrations were quantified by immunoturbidi-
metry (automate A15, BioSystems S.A, Barcelona, Spain)
using BioSystem enzymatic kits (BioSystem).
Statistical analysis
Statistical analysis was performed using Epi-Info version
3.5.1 (CDC, Atlanta, USA), Excel 2003 (Microsoft
Corporation, Redmond, USA) and STATA/SE 11.0 (Stata
Corporation, Texas, and USA). Results are expressed as
mean ± standard deviation and percentage. Descriptive
statistics were used to examine all variables. Baseline
characteristics were compared by using student t-test for
continuous variables and Pearson’s chi-square test for
percentage. Linear regression models (for continuous
variables) and analysis of variance (for categorical vari-
ables) were performed to assess factors associated with
plasma zinc concentration. The variables assessed in re-
lation to baseline plasma zinc concentration were as fol-
lows: elapsed time from last meal to blood draw, elapsed
time from blood draw to centrifugation, elapsed time
from centrifugation to separation of plasma, presence of
visible hemolysis in the plasma sample, and presence of
elevated CRP (≥5 mg/L) and elevated AGP (≥1.0 g/L).
Analysis of covariance (univariate General Linear Model
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BMI, fat free mass and hemoglobin among study groups,
and in plasma zinc concentration, after adjustment for
baseline plasma zinc concentration, CRP and AGP con-
centrations, and elapsed time between the previous food
intake and the time of the blood sampling for the base-
line and final blood draw [29, 30]. All interactions with
the main effect were tested for significance, and non-
significant variables were removed by using a stepwise
procedure. Zinc deficiency was defined according to
IZINCG cut-off. P values 0.05 were considered as
significant.Results
Sixty-five (65) PLWH patients were randomized into 2
groups: RUTF group (n = 32; 24 women and 8 men) and
Control group (n = 33; 14 women and 19 men). During
hospitalization, 6 patients died in the RUTF group and 8
in the Control group. Fifty-one (51) completed the hos-
pital follow up (RUTF group: n = 26; and Control group:
n = 25). After 9 weeks of home monitoring, 3 patients
withdrew the study and 3 died in the RUTF group. In
the Control group, 4 patients died and 4 were lost
during the follow-up. Final analysis concerned 37 pa-
tients, 20 in RUTF group and 17 in Control group as
shown in the profile of study subjects (Fig. 1). There was
any difference in the clinical and anthropometric charac-
teristics between patients who completed the study and
those who did not.Fig. 1 Flow diagramClinical and nutritional characteristics
At enrollment, majority of patients was serology HIV-1
and had stages three and four according to WHO classi-
fication of HIV disease. In each group, over 70 % of the
patients were on ART at enrollment, 19/26 and 19/25
patients in the RUTF and Control group, respectively.
The median CD4 count was comparable in the RUTF
and the Control group (109 ± 137 vs. 128 ± 165 cell/μL;
p = 0.082). Regardless of the group, tuberculosis was the
leading opportunistic infections encountered. Dehydra-
tion, chronic diarrhea and oral candidiasis were also
present at the initial examination of patients in both
groups (Table 2). There were no significant differences
for age and weight between the two groups on admis-
sion. However, the height was significantly higher in the
Control group than in the RUTF group (p = 0.006). After
adjustment for height, BMI, fat free mass (FFM), fat
mass (FM) and percent body fat (%BF) were comparable
between the RUTF and the Control groups (Table 3).
On admission, 19 (30 %) patients had severe chronic
malnutrition (BMI <16.0 kg/m2), 11 patients in the
RUTF group and 8 in the Control group.
Initially, mean hemoglobin: 8.5 ± 2.0 vs. 8.4 ± 2.2
(p = 0.084), and plasma zinc concentration: 68.1 ± 29.8
vs. 68.7 ± 32.4 (p = 0.992), were low in the Control and
the RUTF group, respectively, but were comparable
between groups. Anemia was observed in almost all
patients and over 50 % of them were zinc deficient
according to IZINC cutoff [29]. More than 30 % of the
patients in the Control as well as in the RUTF were
Table 2 Clinical and nutritional status of patients at baseline
Groups
Control (n = 25) RUTF (n = 26) p
Age (y) 42 ± 12 40 ± 12 0.800
Female, % (n) 52 (22) 86 (13) 0.090
HIV-1, % (n) 84 (21) 92 (24) 0.874
ART, % (n) 76 (19) 73 (19) 1.000
CD4 count), 128 ± 148 109 ± 165 0.082
<200 cells/μL, % (n) 84 (19) 81.7 (21) 0.725.
Weight (kg) 51.4 ± 9.8 47.1 ± 9.4 0.121
Height (m) 1.72 ± 0.08 1.66 ± 0.50 0.006
BMI (kg/m2) 17.5 ± 0.6 16.7 ± 0.6 0.711
< 16 kg/m2, % (n) 24 (8) 34 (11) 0.886
TBW (kg) 8.1 ± 2.7 7.7 ± 2.8 0.121
FFM (kg) 11.1 ± 0.4 10.6 ± 0.4 0.121
BF (kg) 39.4 ± 1.2 37.8 ± 1.2 0.651
% BF 78.0 78.2 0.789
Zinc (μg/dL) 68.1 ± 29.8 68.7 ± 32.4 0.992
Zinc deficiency, % (n) 64 (16) 54 (14) 0.765
Hb (μg/dL) 8.5 ± 2.0 8.4 ± 2.2 0.084
Anemia, % (n) 96 (24) 92 (24) 1.000
Chronic infection, % (n) 32 (8) 31 (8) 1.000
Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL
(morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL
(morning nonfasting)
Anemia: women, Hb <12 μg/dL and men Hb <14 μg/dL
Chronic infection: CRP < 5 mg/L and AGP ≥ 1 g/L
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L and AGP ≥ 1 g/L (Table 3).
Dietary intakes
Initially, the total daily energy intake from the standard




Energy(kcal) Women 2100c 1526
Men 2520c 1946
Vitamin A (μg) Women 500 534.7
Men 600 1561
Zinc (mg)d Women 4.9 3.0
Men 7 3.4
Iron (mg)e Women 19.6 1.8
Men 9.1 2.3
aRDA (Recommended Dietary allowances), FAO/WHO [26, 27]
bIntakes measured in addition to the supplement (RUTF + rice porridge)
c RDA of Energy is increased by 20 % to take into account the increase of daily reco
dZinc intake calculated based on the bioavailability of zinc in mixed diets (Hotz and
eIron intakes calculated by taking into account the bioavailability of iron (15 %)1778 ± 708 kcal vs. 1558 ± 692 kcal in the Control and
the RUTF group (p = 0.503). Except for vitamin A require-
ment, the hospital diet associated with the vegetable-
based soup was unable to cover the patient’s requirements
for iron and zinc (Table 3). By improving the diet with
200 g of supplement (100 g RUTF mixed with 100 g rice
porridge), mean daily energy and zinc intakes increased
from 1558 to 2147 kcal, and from 3.4 to 10.6 mg zinc in
the RUTF group, reaching 100 % of requirements for both
nutrients. The supplement also improved the daily intakes
of vitamins C, D, E and vitamins B complex. However, the
iron intake covered only 1/3 of patients’ needs (Table 3).
Effect of the supplement on body composition
No difference was found in the hospital length between
the Control and the RUTF group: 27 ± 18 and 20 ± 10 days
(p = 0.114), respectively. At discharge, clinical and nu-
tritional parameters were comparable in both groups
(Table 4). But, after 9 weeks home-based supplementa-
tion body weight, BMI, fat free mass, fat mass,
hemoglobin were significantly higher (p < 0.05) in the
RUTF group than in the Control group (Table 4).
ANOVAs analysis showed that consumption of 100 g
RUTF for 3 months significantly increased body weight
(+11 %; p = 0.033), fat free mass (+11.8; p = 0.033), fat
mass (+10.7 %; p = 0.032) and decreased body fat per-
centage (p < 0.05) compared to the non-supplemented
group. In the supplemented group, fat free mass in-
creased significantly more in the patients on ART
(+11.7 %, n = 14; p = 0.0001) than in those who did not
received ART (+6.2 %, n = 6; p = 0.032).
Effect of supplement on anemia and zinc status
After 9 weeks, patients in RUTF and Control groups
showed improvement in their hemoglobin level, but the
change in hemoglobin was significantly higher in thedaily recommended intake in both groups
l RUTF









mmended intake for PLWH (WHO, [22])
Brown, [50])
Table 4 Changes in body composition and biological parameters from baseline to 9 weeks in both groups
Baseline Discharge from hospital 9 weeks
Control (n = 25) RUTF (n = 26) p Control (n = 25) RUTF (n = 26) p Control (n = 17) RUTF (n = 20) p
Weight (kg) 51.4 ± 9.8 47.1 ± 9.4a 0.121 50.5 ± 9.6 49.3 ± 9.1 0.651 49.7 ± 8.6 54.2 ± 8.9b 0.009
BMI (kg/m2) 17.5 ± 0.6 16.7 ± 0.6a 0.711 17.3 ± 0.6 17.6 ± 0.6 0.445 16.6 ± 0.7 19.3 ± 0.6b 0.009
TBW (kg) 8.1 ± 2.7 7.7 ± 2.8a 0.121 7.9 ± 0.3 8.1 ± 0.3 0.650 7.7 ± 0.3 8.9 ± 0.3b 0.011
FFM (kg) 11.1 ± 0.4 10.6 ± 0.4a 0.121 10.8 ± 0.4 11.1 ± 0.4 0.650 10.5 ± 0.5 12.3 ± 0.4b 0.011
BF (kg) 39.4 ± 1.2 37.8 ± 1.2a 0.651 38.5 ± 1.4 39.4 ± 1.4 0.651 37.5 ± 1.5 43.4 ± 1.4b 0.009
% BF 78.0 78.2a 0.789 78.1 78.1 1.000 78.1 77.9b 0.888
Zinc (μg/dL) 68.1 ± 29.8 68.7 ± 32.4 0.992 72.6 ± 41.3 59.0 ± 24.2 0.220 71.6 ± 19.4 74.3 ± 45.3 0.811
Zinc deficiency, % (n) 64 (16) 54 (14) 0.765 44 (11) 65 (17) 0.187 41 (7) 65 (13) 0.147
Hb (μg/dL) 8.5 ± 2.0d 8.4 ± 2.2a 0.844 9.7 ± 1.7 9.9 ± 1.9b 0.649 10.0 ± 1.7e 11.8 ± 1.5c 0.002
Anemia, % (n) 96 (24) 92 (24)a 1.000 88 (21) 77 (20) 0.502 94 (16) 50 (10)b 0.003
Groups mean were compared by student t-test (Control vs. RUTF group)
Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL (morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL
(morning nonfasting); Anemia: Hb <12 μg/dL (women) and <14 μg/dL (men)
a, b, a/c and b/c, d/e (p < 0.05): ANOVA for repeated measures with Bonferroni correction within group
Diouf et al. BMC Public Health  (2016) 16:1 Page 7 of 10RUTF than in the Control group: +3.33 ± 0.63 μg/dL
and +0.82 ± 0.49 μg/dL, respectively (p = 0.004). There-
fore, the number of anemic patients decreased signifi-
cantly in the RUTF group (94 to 50 %; p = 0.003)
while it remained unchanged in the Control group (96
to 94 %). Contrary to hemoglobin, the mean change
in plasma zinc concentration was comparable between
the RUTF group and the Control group (p =0.811).
Mean plasma zinc concentrations in both groups did
not differ from their respective baseline values
(Table 4).
Discussion
The present randomized control study was designed to
evaluate the effect of consuming daily 100 g RUTF
mixed with rice porridge as supplement on body com-
position, anemia and zinc status of hospitalized PLWH
in Senegal during hospitalization and after 9 weeks
home-based supplementation. A high prevalence of
severe chronic malnutrition was detected among the
Senegalese PLWH, and according to several authors
[14, 15], the nutritional quality of the patients’ diets
seems to be the immediate cause of this high prevalence
of malnutrition, even thought others causes like de-
crease food consumption due to several factors, espe-
cially anorexia accompanying opportunistic infections,
may be suspected [8]. In this study, the standard hos-
pital diet as well as diets provided by the relatives, even
fortified with a vegetable soup was unable to cover the
patients’ needs. Improving the diet with a high-energy
dense fortified supplement, consisting of 100 g RUTF
mixed with rice porridge improved significantly the diet
in term of energy, vitamins (B complex vitamins except
for biotin, C, D, E, and minerals intakes (zinc, selenium,
cooper, calcium, potassium, phosphorus, magnesium).Low serum levels of calcium, potassium, and magne-
sium have been reported in HIV-infected population
[31–33]. In contrast, high plasma concentration of cop-
per was founded early in the course of HIV infection
[34], due to the increase of this mineral during the
acute-phase response in a variety of infections and in-
flammatory conditions. However, the effect of supple-
mentation with these minerals on HIV population was
poorly investigated and requires further research.
The daily recommended intake of vitamin A in our pa-
tients was covered by consumption of a vegetable-based
soup prepared by the hospital and rich in beta-carotene.
But we did not investigated the others nutrients in the
soup. The home diet of the patients was not measured
but it is expected the vitamin A stores gained during
hospitalization remains for several weeks.
This was not the case for iron. During hospitalization,
iron intake from the patients’ diet was very low as well
as the iron content of 100 g RUTF. Although the supple-
mentation increased a bit the iron intake of the RUTF
group, it did not reach the daily recommended intake,
and all the positive effects on the hemoglobin level in
this group cannot be assigned to iron intake. In a previ-
ous study from our laboratory (unpublished data), we
showed that Senegalese outpatients PLWH with anemia
were not iron deficient according to their plasma ferritin
concentration or serum transferrin receptor. In the present
study, the prevalence of anemia was and remained high
after 9 weeks follow-up in both groups, and these results
are similar to those reported by others [14, 16, 35]. The
failure of erythropoiesis is generally considered as the
primary physiopathological mechanism of anemia in
HIV-associated opportunistic infections, micronutrient
deficiencies, direct effect of HIV on erythropoiesis and
tuberculosis mediated-anemia [36–38]. The positive effect
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nificant reduction of the anemic patients in the RUTF
group at 9 weeks were not correlated with their iron in-
take. It is reported that iron supplementation have a nega-
tive effect on HIV-infection [39]. In our study, the iron
intake from the supplement was very low (2.9 mg/day)
and was not expected to have similar negative affects
when high dose of iron (30 to 60 mg/day) were adminis-
trated. This result suggests an anabolic effect of other
micronutrients from the RUTF, perhaps increased intakes
of B12 and folic acid. The positive effect of vitamins B
complex on wasting has been demonstrated by several
authors [40, 41]. Irlam et al., in the recent Cochrane re-
view showed that multivitamin supplementation trial i-
ncreased weight gain in PLWH co-infected with TB and
HIV [40]. These results of vitamins on wasting could be re-
lated to their effects at various levels of immunity [42, 43].
Furthermore, recent studies support beneficial effects of
micronutrient supplementation (vitamin B complex, vita-
min C and E) at RDA level in HIV-infected people [44, 45].
At the end of the hospitalization period, any beneficial
effect of the supplementation was observed on body com-
position but after 9 weeks home supplementation, the
change in body composition was highly significant from
baseline (+11 % body mass). The increase in fat free mass
in the RUTF group could be explained by the increase
coverage of certain nutrients, particularly vitamins and
minerals. It could also result from the reduction of oppor-
tunistic infections during hospitalization. Infectious epi-
sodes are accompanied by increase protein catabolism
which partially explains the high rate of severe malnutri-
tion observed in our patients in both groups, and their
low initial fat free mass. Also, multivitamins could directly
avert muscle loss by decreasing the oxidative stress that
has been found to result in muscle wasting [42, 43].
However, in the present study, reduction of .opportun-
istic infections was observed in the RUTF as well as in
the Control, since it was the discharge criteria from the
hospital. Therefore, it is more likely that the significant
improvement in body composition in the RUTF group
compared to the Control group can be assigned to the
supplement. Increase of fat free mass has been reported
by others authors even with lower dose of RUTF [14, 15].
Diouf et al. in a study on adults outpatients PLWH sup-
plemented with 43 g of RUTF per day showed an increase
in fat free mass of about 7.7 % after 6 months of supple-
mentation [14]. With higher dose of RUTF (245 g of
RUTF/d) over a period of 3.5 months, Ndekha et al. also
demonstrate an increase in lean mass, but, in contrast
with our study, food consumption was not measured [15].
In the present study, the percentage increase in fat free
mass after 3 months of supplementation was 11.8 % indi-
cating that an unbalance diets supplemented with 100 g
RUTF can lead to a significant positive effect on musclemass without increasing the % body fat. These results sug-
gested that the energy intake of 100 g RUTF (an energy
dense fortified food) is sufficient to optimize the use of
other nutrients that causes a significant gain in body mass,
probably because the amount of energy supplied by 100 g
RUTF (>500 kcal). It is well known that energy density is
a determinant of food consumption [46] and can increase
the chances of nutritional recovery of severely malnour-
ished HIV-infected patients in sub Saharan Africa with
BMI less than 17 kg/m2 [47]. Yet, the vitamin/mineral
content of 100 g RUTF as food complement needs more
investigations according to local diet habits. We showed
in the present study that such quantity is well accepted by
PLWH and has positive effect on their nutritional status.
The prevalence of zinc deficiency was high (50 %) in
both groups although the supplement had covered the
zinc requirements in the RUTF group. High prevalence
of zinc deficiency in PLWH has been reported by other
authors [20, 48]. In the present study, zinc intake was in-
creased with the supplementation to more than one
RDA of zinc as recommended by WHO [22]. RUTF is a
zinc-fortified food but the fortification was not reflected
on the plasma zinc concentration of the patients. This
result suggested that either one RDA is not enough to
cover the zinc requirement of PLWH, or the concentra-
tion of plasma zinc does not reflect zinc status during
fortification contrary to zinc supplementation. In our la-
boratory, we have demonstrated that plasma zinc con-
centration increased in children and adults who received
daily zinc supplementation for a short time but not in
those who received a zinc-fortified food containing a
similar amount of zinc [24, 49]. Also, Mocchegiani et al.
showed that zinc supplementation with 3 times the RDA
increases significantly the plasma zinc of PLWH [21].
The question remains open and needs additional studies
to assess the usefulness of plasma zinc as biomarker of zinc
fortification. Moreover, the disturbance in the homeostasis
of zinc, particularly, the redistribution of zinc to the liver
and the presence of inflammatory cytokines or proteins
may be implicated in the etiology of zinc deficiency among
PLWH as well as the use of zinc for the expression of
genes and the replication of HIV [50].
Conclusion
Severe chronic malnutrition is highly prevalent among
Senegalese hospitalized PLWH with a significant loss of
fat free mass. The patient’s usual diet did not cover most
of the nutrient requirements, including energy. Im-
proving this diet with a supplement consisting of 100 g
RUTF (a high energy dense fortified food) mixed in
rice allowed to cover the RDA of many micronutrients
including zinc for PLWH. The supplement had a posi-
tive effect on body composition by increasing the
amount of lean and fat mass and maintaining % body
Diouf et al. BMC Public Health  (2016) 16:1 Page 9 of 10fat. Within the supplemented group, food + treatment
were better at restoring fat free mass and resolving
anemia than treatment alone. The anemic status of the
patients was also significantly improved despite a low
iron intake. It is possible that the supplement has im-
proved the zinc status of the PLWH (fat free mass de-
posit increased), but we were unable to confirm such
improvement as their plasma zinc concentration failed
to reflect it. Research is needed to identify more sensi-
tive indicator of zinc status in PLWH in response to
zinc fortification. However, from the overall results,
this study, we would like to recommend supplementa-
tion of adult PLWH with 100 g RUTF in the early
stage of the infection.
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